Results 211 to 220 of about 683,284 (269)

Multparametric Magnetic Resonance Imaging and 68-Gallium-Prostate-Specific-Membrane-Antigen-Ligand Positron Emission Tomography for evaluation a regional lymph nodes in patients with biochemical recurrent prostate cancer, initial data of single centre study

, 2019
Liene Zemniece
openalex   +1 more source

scPER: A Rigorous Computational Approach to Determine Cellular Subtypes in Tumors Aligned With Cancer Phenotypes From Total RNA Sequencing

Advanced Science, EarlyView.
scPER presents an adversarial‐autoencoder framework that deconvolves bulk total RNA‐seq to quantify tumor‐microenvironment cell types and uncover phenotype‐linked subclusters. Across diverse benchmarks, scPER improves accuracy over existing tools.
Bingrui Li, Xiaobo Zhou, Raghu Kalluri
wiley   +1 more source

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden. [PDF]

Cancer Epidemiol Biomarkers Prev
Lin E, Garmo H, Beckmann K, Bratt O, Stattin P, Gedeborg R.   +5 more
europepmc   +1 more source

Magnesium Structure‐Function Integration Platform for Spatiotemporal Multi‐Modality Therapy: Combining Hormonotherapy and Immunotherapy in Prostate Cancer

Advanced Science, EarlyView.
The schematic illustration of the MHSCG platform for spatiotemporal responsive GRb1 release to induce androgen deprivation therapy (ADT) and immunogenic cell death (ICD) multimodal therapy in prostate cancer. Abstract Metal‐based immunotherapy represents a promising strategy for enhancing antitumor efficacy; however, its clinical application is limited
Rui Zan, Qianping Mao, Keyi Wang, Guodong Zou, Shi Yang, Hua Qiu, Xiang Fang, Guiqing Wang, Xinyi Zhou, Jiexia Wen, Shuai Jiang, Ran Huang, Qiuming Peng, Tao Suo   +13 more
wiley   +1 more source

Evaluating the impact of a community-based prostate cancer screening program. [PDF]

Arch Public Health
Leader AE, Pham K, Cianci N, Knapp H, Doka F, Barron S, Kolesnikov O, DeHoratius J, Bradley K, Robles L, Giamboy R, Dahlgren O, Gomella LG.   +12 more
europepmc   +1 more source

Referral Network Increases Physicians’ Adoption of Active Surveillance for Localized Prostate Cancer: A Cross-Sectional Study Using SEER-Medicare

Yu Liu, David H. Howard, Ya‐Chen Tina Shih   +2 more
openalex   +1 more source

Osmotic Tension Asymmetry Drives Electrotactic Migration via PDLIM7‐Polarized Microfilament Coordination in Breast Cancer Cells

Advanced Science, EarlyView.
This study establishes an electric field‐induced directional migration model using fluorescence tension probes to visualize microfilament forces and intracellular osmotic pressure dynamics in the electrotactic migration of breast cancer cells. This model delineates how electromechanical interactions among membrane potential, ion channels, OP, traction ...
Ling Zhu, Zihui Zheng, Wang Li, Chenyi Shou, Ying Zhao, Lijun Zhang, Xiaoli Shi, Yunfeng Hu, Huanhuan Zhao, Huiwen Wu, Jun Guo   +10 more
wiley   +1 more source

Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how? [PDF]

Fam Cancer
Edmunds K, Arora S, Teppala S, Scuffham P, Fairbairn D, Roberts MJ, Horvath L, Smith DP, Tuffaha H.   +8 more
europepmc   +1 more source

Esketamine/Ketamine: Dual‐Action Mechanisms and Clinical Prospects beyond Anesthesia in Psychiatry, Immunology, and Oncology

Advanced Science, EarlyView.
Esketamine and ketamine are widely used for perioperative analgesia and anesthesia. Despite their established roles in analgesia, sedation, and anesthesia, as well as emerging antidepressant, anti‐tumor, and anti‐inflammatory effects, their clinical use is limited due to side effects and addiction potential.
Yinxin Wang, Jiangang Xu, Xinyu Zhou, Lu Che, Minghan Qiu, Yang Liu, Ming Gao, Zhen Yang   +7 more
wiley   +1 more source

Current and future perspectives on radioligand therapy in advanced prostate cancer. [PDF]

Ther Adv Med Oncol
Ahmed B, Ravi P.
europepmc   +1 more source